Kura Oncology Inc (KURA)
20.59
+0.31
(+1.53%)
USD |
NASDAQ |
May 02, 16:00
20.59
0.00 (0.00%)
After-Hours: 18:08
Kura Oncology 1 Year Total Returns (Daily): 94.25% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | 94.25% |
April 30, 2024 | 101.4% |
April 29, 2024 | 106.0% |
April 26, 2024 | 93.98% |
April 25, 2024 | 77.07% |
April 24, 2024 | 74.26% |
April 23, 2024 | 70.27% |
April 22, 2024 | 65.36% |
April 19, 2024 | 54.72% |
April 18, 2024 | 60.58% |
April 17, 2024 | 56.30% |
April 16, 2024 | 62.50% |
April 15, 2024 | 66.17% |
April 12, 2024 | 66.50% |
April 11, 2024 | 70.57% |
April 10, 2024 | 65.97% |
April 09, 2024 | 66.91% |
April 08, 2024 | 64.81% |
April 05, 2024 | 70.52% |
April 04, 2024 | 66.61% |
April 03, 2024 | 59.15% |
April 02, 2024 | 67.78% |
April 01, 2024 | 78.41% |
March 28, 2024 | 72.71% |
March 27, 2024 | 75.98% |
Date | Value |
---|---|
March 26, 2024 | 73.20% |
March 25, 2024 | 78.03% |
March 22, 2024 | 77.89% |
March 21, 2024 | 73.01% |
March 20, 2024 | 78.81% |
March 19, 2024 | 84.91% |
March 18, 2024 | 79.37% |
March 15, 2024 | 91.10% |
March 14, 2024 | 87.54% |
March 13, 2024 | 103.5% |
March 12, 2024 | 108.3% |
March 11, 2024 | 113.1% |
March 08, 2024 | 112.4% |
March 07, 2024 | 97.52% |
March 06, 2024 | 100.2% |
March 05, 2024 | 78.76% |
March 04, 2024 | 81.05% |
March 01, 2024 | 80.67% |
February 29, 2024 | 76.85% |
February 28, 2024 | 79.36% |
February 27, 2024 | 83.47% |
February 26, 2024 | 77.26% |
February 23, 2024 | 68.33% |
February 22, 2024 | 63.80% |
February 21, 2024 | 69.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.25%
Minimum
Dec 14 2021
302.2%
Maximum
Mar 18 2021
10.28%
Average
-9.59%
Median
Nov 21 2022
1 Year Total Returns (Daily) Benchmarks
Tivic Health Systems Inc | -92.03% |
AIM ImmunoTech Inc | -15.22% |
Perspective Therapeutics Inc | 176.8% |
Protalix BioTherapeutics Inc | -58.28% |
Armata Pharmaceuticals Inc | 54.84% |